Cordatus Wealth Management LLC boosted its position in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 1.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 22,915 shares of the company’s stock after purchasing an additional 251 shares during the period. Cordatus Wealth Management LLC’s holdings in Colgate-Palmolive were worth $2,083,000 at the end of the most recent reporting period.
Several other hedge funds also recently modified their holdings of CL. FMR LLC grew its holdings in shares of Colgate-Palmolive by 65.6% in the 3rd quarter. FMR LLC now owns 6,749,275 shares of the company’s stock valued at $700,642,000 after acquiring an additional 2,674,807 shares in the last quarter. Barclays PLC grew its holdings in shares of Colgate-Palmolive by 38.7% in the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock valued at $793,542,000 after acquiring an additional 2,132,747 shares in the last quarter. State Street Corp grew its holdings in shares of Colgate-Palmolive by 3.8% in the 3rd quarter. State Street Corp now owns 48,436,276 shares of the company’s stock valued at $5,028,170,000 after acquiring an additional 1,784,411 shares in the last quarter. Nordea Investment Management AB grew its holdings in shares of Colgate-Palmolive by 32.5% in the 4th quarter. Nordea Investment Management AB now owns 5,091,683 shares of the company’s stock valued at $462,121,000 after acquiring an additional 1,247,731 shares in the last quarter. Finally, AustralianSuper Pty Ltd grew its holdings in Colgate-Palmolive by 941.9% during the fourth quarter. AustralianSuper Pty Ltd now owns 1,138,655 shares of the company’s stock worth $103,515,000 after purchasing an additional 1,029,364 shares during the period. Institutional investors own 80.41% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of equities analysts recently commented on the company. Wells Fargo & Company reduced their price target on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a report on Tuesday, January 7th. Stifel Nicolaus reduced their price target on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a report on Monday, February 3rd. JPMorgan Chase & Co. reduced their price target on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a report on Monday, February 3rd. Morgan Stanley reduced their price target on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a report on Monday, February 3rd. Finally, Royal Bank of Canada reiterated a “sector perform” rating and set a $101.00 price target on shares of Colgate-Palmolive in a report on Wednesday, January 29th. One research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat, Colgate-Palmolive presently has an average rating of “Hold” and an average target price of $101.16.
Colgate-Palmolive Stock Performance
Shares of NYSE:CL opened at $87.80 on Friday. The company’s 50 day simple moving average is $89.02 and its 200 day simple moving average is $95.99. The stock has a market capitalization of $71.25 billion, a price-to-earnings ratio of 24.94, a price-to-earnings-growth ratio of 4.12 and a beta of 0.44. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. Colgate-Palmolive has a 1 year low of $84.45 and a 1 year high of $109.30.
Colgate-Palmolive (NYSE:CL – Get Free Report) last posted its earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the previous year, the firm earned $0.87 EPS. As a group, research analysts predict that Colgate-Palmolive will post 3.76 EPS for the current fiscal year.
Colgate-Palmolive Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st were paid a dividend of $0.50 per share. The ex-dividend date was Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.28%. Colgate-Palmolive’s payout ratio is presently 56.82%.
Colgate-Palmolive Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading
- Five stocks we like better than Colgate-Palmolive
- What Are the FAANG Stocks and Are They Good Investments?
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- How to Read Stock Charts for Beginners
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- What is the Shanghai Stock Exchange Composite Index?
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.